- Published
- 2025-03-05
- Venue
- Frontiers in Medicine, vol. 12, pp. 1544393
- Cited by
- 283
- Open access
- Yes, gold
- DOI
- 10.3389/fmed.2025.1544393
- PubMed
- 40109724
Abstract
The integration of nanotechnology into healthcare has introduced Nanotechnology-Enabled Health Products (NHPs), promising revolutionary advancements in medical treatments and diagnostics. Despite their potential, the regulatory navigation for these products remains complex and often lagging, creating barriers to their clinical application. This review article focuses on dissecting the regulatory landscape for NHPs, particularly in the European Union and the United States, to identify applicable requirements and the main regulatory guidelines currently available for meeting regulatory expectations.
Cite this paper
Formatted from the source metadata, not typed by hand. For a whole reference list, use the citation generator or ask your assistant through Find Research.
- APA 7
Rodríguez-Gómez, F. D., Monferrer, D., Penon, O., & Rivera-Gil, P. (2025). Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks. Frontiers in Medicine, 12, 1544393. https://doi.org/10.3389/fmed.2025.1544393
- MLA 9
Rodríguez-Gómez, Francisco D., et al. "Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks." Frontiers in Medicine, vol. 12, 2025, pp. 1544393, https://doi.org/10.3389/fmed.2025.1544393.
- Chicago
Rodríguez-Gómez, Francisco D., Dominique Monferrer, Oriol Penon, and Pilar Rivera-Gil. "Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks." Frontiers in Medicine 12 (2025): 1544393. https://doi.org/10.3389/fmed.2025.1544393.
- GOST
Rodríguez-Gómez F. D., Monferrer D., Penon O. [и др.] Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks // Frontiers in Medicine. — 2025. — Vol. 12. — P. 1544393. — URL: https://doi.org/10.3389/fmed.2025.1544393
- BibTeX
@article{rodriguezgomez2025regulatory, title = {{Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks}}, author = {Francisco D. Rodríguez-Gómez and Dominique Monferrer and Oriol Penon and Pilar Rivera-Gil}, journal = {Frontiers in Medicine}, year = {2025}, volume = {12}, pages = {1544393}, doi = {10.3389/fmed.2025.1544393}, url = {https://doi.org/10.3389/fmed.2025.1544393} }- RIS
TY - JOUR AU - Rodríguez-Gómez, Francisco D. AU - Monferrer, Dominique AU - Penon, Oriol AU - Rivera-Gil, Pilar TI - Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks JO - Frontiers in Medicine VL - 12 SP - 1544393 PY - 2025 DA - 2025/03/05 DO - 10.3389/fmed.2025.1544393 UR - https://doi.org/10.3389/fmed.2025.1544393 ER -